|本期目录/Table of Contents|

[1]韩 君,徐兴祥.智能化管理对COPD恢复期患者的影响[J].中华肺部疾病杂志,2022,(02):243-245.[doi:10.3877/cma.j.issn.1674-6902.2022.02.027]
点击复制

智能化管理对COPD恢复期患者的影响(PDF)

《中华肺部疾病杂志》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2022年02期
页码:
243-245
栏目:
短篇论著
出版日期:
2022-04-20

文章信息/Info

Title:
-
作者:
韩 君1; 徐兴祥2
232000 淮南,安徽理工大学第一附属医院呼吸与危重症医学科1 225002 扬州,苏北人民医院呼吸与危重症医学科2
Author(s):
-
关键词:
恢复期; 肺疾病; 慢性阻塞性;  智能化管理;  药物依从性;  住院重返率
Keywords:
-
分类号:
R563
DOI:
10.3877/cma.j.issn.1674-6902.2022.02.027
摘要:
-
Abstract:
-

参考文献/References:

1 Gadoury MA, Schwartzman K, Rouleau M, et al. Self-management reduces both short- and long-term hospitalisation in COPD[J]. Eur Respir J, 2005, 26(5): 853-857.
2 Bourebau J, Julen M, Maltais F, et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention[J]. Arch Int Med, 2003, 163(5): 585-591.
3 Donaldson GC, Seemungal TAR, Patel IS, et al. Longitudinal changes in the nature, severity and frequency of COPD exacerbations[J]. Eur Respir J, 2003, 22(6): 931-936.
4 Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease(revised 2017)[EB/OL].http://www.goldcopd.org/guidelines-pocket-guide-to-copd-diagnosis.html, 2017.
5 任成山, 王关嵩, 钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 127-141.
6 Chapman KR, Mannino DM, Soriano JB, et al. Epidemiology and costs of chronic obstructive pulmonary disease[J]. Eur Respir, 2006, 27: 188.
7 Judith Garcia-Aymerich, Ignasi Serra Pons, David M Mannino, et al. Lung function impairment, COPD hospitalisations and subsequent mortality[J]. Thorax, 2011, 66(7): 585-590.
8 Weatherall M, Marsh S, Shirtcliffe P, et al. Quality of life measured by the st george's respiratory questionnaire and spirometry[J]. Eur Respir J, 2009, 33(5): 1025-1030.
9 Edmond L Toy, Nicolas U Beaulieu, Joshua M McHale, et al. Treatment of COPD: relationships between daily dosing frequency, adherence, resource use, and costs[J]. Respir Med, 2011, 105(3): 435-441.
10 Ramsey SD. Suboptimal medical therapy in COPD: exploring the causes and consequences[J]. Chest, 2000, 117(2 Suppl): 33S-37S.
11 Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence measure in an outpatient setting[EB/OL]. Clin Hypertens(Greenwich), 2008, 10: 348-354.
12 Morisky DE, DiMatteo MR. Improving the measurement of self-reported medication nonadherence: Final response[EB/OL]. J Clin Epidemiol, 2011, 64: 262-263.
13 Rohr R. Rehospitalizations among patients in the Medicare fee-for-service program[J]. N Engl J Med, 2009, 361(3): 311-312.
14 Shih-Feng Liu, Kuan-Chun Lin, Chien-Hung Chin, et al. Factors influencing short-term re-admission and one-year mortality in patients with chronic obstructive pulmonary disease[J]. Respirology, 2007, 12(4): 560-565.
15 Shih-Feng Liu, Kuan-Chun Lin, Chien-Hung Chin, et al. Factors influencing short-term re-admission and one-year mortality in patients with chronic obstructive pulmonary disease[J]. Respirology, 2007, 12(4): 560-565.
16 MeiLan K Han, Carlos H Martinez, David H Au, et al. Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective[J]. Lancet Respir Med, 2016, 4(6): 473-526.
17 Earl S Ford, ?Louise B Murphy, ?Olga Khavjou, et al. Total and state-specific medical and absenteeism costs of COPD among adults aged 18 years in the United States for 2010 and projections through 2020[J]. Chest, 2015, 147(1): 31-45.
18 Pozo-Rodriguez F, Lopez-Campos JL, Alvarez-Martinez CJ, et al. Clinical audit of COPD patients requiring hospital admission in Spain: AUDIPOC study[J]. PLoS One, 2012, 7(7): e42156.
19 Makris D, Moschandreas J, Damianaki A, et al. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers[J]. Respir Med, 2007, 101(6):1305-1312.
20 Friedman B, Jiang HJ, Elixhauser A. Costly hospital readmissions and complex chronic illness[J]. Inquiry, 2008, 45(4): 408-421.
21 Bai-qiang Cai, Shao-xi Cai, Rong-chang Chen, et al. Expert consensus on acute exacerbation of chronic obstructive pulmonary disease in the People's Republic of China[J]. Int J Chron Obstruct Pulmon Dis, 2014, 9: 381-395.
22 Scott D Ramsey, Richard Hobbs FD. Chronic obstructive pulmonary disease, risk factors, and outcome trials: comparisons with cardiovascular disease[J]. Proc Am Thorac Soc, 2006, 3(7): 635-640.
23 Morten H Jensen, Simon L Cichosz, Birthe Dinesen, et al. Moving prediction of exacerbation in chronic obstructive pulmonary disease for patients in telecare[J]. J Telemed Telecare, 2012, 18(2): 99-103.
24 Claudio Pedone, Domenica Chiurco, Simone Scarlata, et al. Efficacy of multiparametric telemonitoring on respiratory outcomes in elderly people with COPD: a randomized controlled trial[J]. BMC Health Serv Res, 2013, 13: 82.
25 Hasan Rehman, Ayeesha K Kamal, Pamela B Morris, et al. Mobile health(mHealth)technology for the Management of hypertension and hyperlipidemia: slow start but loads of potential[J]. Curr Atheroscler Rep, 2017, 19(3): 12.
26 Hannah Kang, Hyeoun-Ae Park. A mobile app for hypertension Management based on clinical practice guidelines: development and deployment[J]. JMIR Mhealth Uhealth, 2016, 4(1): e12.
27 Fen Yang, Yuncui Wang, Chongming Yang, et al. Mobile health applications in self-management of patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis of their efficacy[J]. BMC Pulm Med, 2018, 18(1): 147.
28 Dale J, Connor S, Tolley K. An evaluation of the west surrey telemedicine monitoring project[J]. J Telemed Telecare, 2003, 9(Suppl 1): S39-S41.

备注/Memo

备注/Memo:
通信作者: 徐兴祥, Email: xuxx63@sina.com
更新日期/Last Update: 2022-04-20